TSLA Stock Analysis: Tesla | NASDAQ
Auto Manufacturers | NASDAQ, USA | Market Cap: 1.342.688m USD | 12M Return: 0.5% | US88160R1014 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 11.9B
EPS Trend: -95.5%
Qual. Beats: 0
Rev. Trend: 37.9%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Tesla, Inc. (TSLA) is a U.S.-based automaker and energy company operating through two main segments: Automotive and Energy Generation and Storage. The Automotive segment designs, manufactures, and sells battery-electric vehicles, including sedans and SUVs, distributed through direct sales, used vehicle channels, and a proprietary Supercharger network, while also offering financing, leasing, insurance, maintenance, and vehicle software/in-app upgrades. The Energy Generation and Storage segment produces and installs solar panels, Solar Roof, and lithium-ion battery products (Powerwall and Megapack) for residential, commercial, industrial, and utility customers via direct channels and partners.
Beyond vehicle and hardware sales, Tesla generates recurring revenue streams through software services (including its Full Self-Driving/Autopilot advanced driver-assistance suite), automotive regulatory credit sales, extended service plans, and energy storage product financing. The company is also developing humanoid robotics (Optimus) and AI/robotaxi services, positioning itself as an integrated clean-energy and artificial intelligence platform rather than a pure-play automaker. Tesla was incorporated in 2003, IPOd on NASDAQ in June 2010, and is headquartered in Austin, Texas, with operations in the U.S., China, and other international markets.
- Automotive margins compress on repeated vehicle price cuts
- Energy storage revenue accelerates with Megapack deployments
- Chinese EV competition intensifies from BYD and Xiaomi
| Net Income: 3.82b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.47 > 1.0 |
| NWC/Revenue: 32.17% < 20% (prev 33.57%; Δ -1.40% < -1%) |
| CFO/TA 0.13 > 3% & CFO 18.7b > Net Income 3.82b |
| Net Debt (-27.2b) to EBITDA (12.0b): -2.26 < 3 |
| Current Ratio: 1.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.54b) vs 12m ago 0.60% < -2% |
| Gross Margin: 18.85% > 18% (prev 17.48%; Δ 1.37% > 0.5%) |
| Asset Turnover: 74.79% > 50% (prev 72.12%; Δ 2.67% > 0%) |
| Interest Coverage Ratio: 16.62 > 6 (EBIT TTM 5.55b / Interest Expense TTM 334.0m) |
| A: 0.22 (Total Current Assets 68.8b - Total Current Liabilities 35.4b) / Total Assets 149b |
| B: 0.27 (Retained Earnings 40.6b / Total Assets 149b) |
| C: 0.04 (EBIT TTM 5.55b / Avg Total Assets 139b) |
| D: 1.42 (Book Value of Equity 86.9b / Total Liabilities 61.1b) |
| Altman-Z'' = 4.13 = AA |
| DSRI: 0.95 (Receivables 4.09b/3.84b, Revenue 104b/92.7b) |
| GMI: 0.93 (GM 17.48% / 18.85%) |
| AQI: 1.44 (AQ_t 0.15 / AQ_t-1 0.10) |
| SGI: 1.12 (Revenue 104b / 92.7b) |
| TATA: -0.10 (NI 3.82b - CFO 18.7b) / TA 149b) |
| Beneish M = -2.80 (Cap -4..+1) = A |
As of August 19, 2026, the stock is trading at USD 336.87 with a total of 27,113,653 shares traded. Over the past week, the price has changed by +1.22%, over one month by -8.85%, over three months by -17.83% and over the past year by +0.51%.
Current recommended Stop Loss: 319.30 (which is 5.2% or 1.3 ATR below the current price).
Tesla has received a consensus analysts rating of 3.38. Therefore, it is recommended to hold TSLA.
- StrongBuy: 14
- Buy: 7
- Hold: 16
- Sell: 3
- StrongSell: 7
| Analysts Target Price | 396.6 | 17.7% |
P/E Trailing = 314.7778
P/E Forward = 169.4915
P/S = 12.9579
P/B = 15.0455
P/EG = 4.8481
Revenue TTM = 104b USD
EBIT TTM = 5.55b USD
EBITDA TTM = 12.0b USD
Long Term Debt = 7.72b USD (from longTermDebt, last quarter)
Short Term Debt = 1.42b USD (from shortTermDebt, last quarter)
Debt = 16.4b USD (from shortLongTermDebtTotal, last quarter) + Leases 7.02b
Net Debt = -27.2b USD (calculated: Debt 16.4b - CCE 43.5b)
Enterprise Value = 1316b USD (1343b + Debt 16.4b - CCE 43.5b)
Interest Coverage Ratio = 16.62 (Ebit TTM 5.55b / Interest Expense TTM 334.0m)
EV/FCF = 228.3x (Enterprise Value 1316b / FCF TTM 5.76b)
FCF Yield = 0.44% (FCF TTM 5.76b / Enterprise Value 1316b)
FCF Margin = 5.56% (FCF TTM 5.76b / Revenue TTM 104b)
Net Margin = 3.68% (Net Income TTM 3.82b / Revenue TTM 104b)
Gross Margin = 18.85% ((Revenue TTM 104b - Cost of Revenue TTM 84.1b) / Revenue TTM)
Gross Margin QoQ = 16.83% (prev 21.08%)
Tobins Q-Ratio = 8.86 (Enterprise Value 1316b / Total Assets 149b)
Interest Expense / Debt = 2.04% (Interest Expense 334.0m / Debt 16.4b)
Taxrate = 25.93% (1.35b / 5.22b)
NOPAT = 4.11b (EBIT 5.55b * (1 - 25.93%))
Current Ratio = 1.94 (Total Current Assets 68.8b / Total Current Liabilities 35.4b)
Debt / Equity = 0.19 (Debt 16.4b / totalStockholderEquity, last quarter 86.9b)
Debt / EBITDA = -2.26 (Net Debt -27.2b / EBITDA 12.0b)
Debt / FCF = -4.71 (Net Debt -27.2b / FCF TTM 5.76b)
Total Stockholder Equity = 83.3b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.76% (Net Income 3.82b / Total Assets 149b)
RoE = 4.59% (Net Income TTM 3.82b / Total Stockholder Equity 83.3b)
RoCE = 6.10% (EBIT 5.55b / Capital Employed (Equity 83.3b + L.T.Debt 7.72b))
RoIC = 3.76% (NOPAT 4.11b / Invested Capital 109b)
WACC = 14.16% (E(1343b)/V(1359b) * Re(14.31%) + D(16.4b)/V(1359b) * Rd(2.04%) * (1-Tc(0.26)))
Discount Rate = 14.31% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 95.16 | Cagr: 0.71%
[DCF] Terminal Value 58.48% ; FCFF base≈5.69b ; Y1≈5.86b ; Y5≈6.54b
[DCF] Fair Price = 19.73 (EV 50.7b - Net Debt -27.2b = Equity 77.9b / Shares 3.95b; r=14.16% [WACC]; 5y FCF grow 3.15% → 2.50% )
EPS Correlation: -95.53 | EPS CAGR: -22.13% | SUE: 0.12 | # QB: 0
Revenue Correlation: 37.92 | Revenue CAGR: 1.14% | SUE: 1.55 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.46 | Chg30d=-15.55% | Revisions=-41% | Analysts=27
EPS current Year (2026-12-31): EPS=1.79 | Chg30d=-12.67% | Revisions=-44% | GrowthEPS=+7.8% | GrowthRev=+11.6%
EPS next Year (2027-12-31): EPS=2.22 | Chg30d=-11.87% | Revisions=-58% | GrowthEPS=+24.0% | GrowthRev=+13.9%
[Analyst] Revisions Ratio: -52% (up=15, down=51)